123 related articles for article (PubMed ID: 10940682)
1. Molecular genetics of neuroendocrine tumors.
Calender A
Digestion; 2000; 62 Suppl 1():3-18. PubMed ID: 10940682
[TBL] [Abstract][Full Text] [Related]
2. Genetic testing in multiple endocrine neoplasia and related syndromes.
Calender A
Forum (Genova); 1998; 8(2):146-59. PubMed ID: 9666051
[TBL] [Abstract][Full Text] [Related]
3. [Multiple endocrine neoplasia: genetic aspects].
Calender A;
Bull Acad Natl Med; 2010 Jan; 194(1):81-95; discussion 95-6. PubMed ID: 20669561
[TBL] [Abstract][Full Text] [Related]
4. [Clinical genetics of neuroendocrine tumors].
Karges W; Adler G
Med Klin (Munich); 2003 Dec; 98(12):712-6. PubMed ID: 14685672
[TBL] [Abstract][Full Text] [Related]
5. Thoracic and duodenopancreatic neuroendocrine tumors in multiple endocrine neoplasia type 1: natural history and function of menin in tumorigenesis.
Pieterman CR; Conemans EB; Dreijerink KM; de Laat JM; Timmers HT; Vriens MR; Valk GD
Endocr Relat Cancer; 2014 Jun; 21(3):R121-42. PubMed ID: 24389729
[TBL] [Abstract][Full Text] [Related]
6. The genetics of neuroendocrine tumors.
Öberg K
Semin Oncol; 2013 Feb; 40(1):37-44. PubMed ID: 23391111
[TBL] [Abstract][Full Text] [Related]
7. Recessive transmission of a multiple endocrine neoplasia syndrome in the rat.
Fritz A; Walch A; Piotrowska K; Rosemann M; Schäffer E; Weber K; Timper A; Wildner G; Graw J; Höfler H; Atkinson MJ
Cancer Res; 2002 Jun; 62(11):3048-51. PubMed ID: 12036912
[TBL] [Abstract][Full Text] [Related]
8. Somatic and germline mutations in NETs: Implications for their diagnosis and management.
Minnetti M; Grossman A
Best Pract Res Clin Endocrinol Metab; 2016 Jan; 30(1):115-27. PubMed ID: 26971848
[TBL] [Abstract][Full Text] [Related]
9. Pheochromocytoma in von Hippel-Lindau disease and neurofibromatosis type 1.
Opocher G; Conton P; Schiavi F; Macino B; Mantero F
Fam Cancer; 2005; 4(1):13-6. PubMed ID: 15883705
[TBL] [Abstract][Full Text] [Related]
10. Review: multiple endocrine neoplasia type 1, sporadic neuroendocrine tumors, and MENIN.
Komminoth P
Diagn Mol Pathol; 1999 Sep; 8(3):107-12. PubMed ID: 10565680
[TBL] [Abstract][Full Text] [Related]
11. Distinct DNA Methylation Signatures in Neuroendocrine Tumors Specific for Primary Site and Inherited Predisposition.
Tirosh A; Killian JK; Petersen D; Zhu YJ; Walker RL; Blau JE; Nilubol N; Patel D; Agarwal SK; Weinstein LS; Meltzer P; Kebebew E
J Clin Endocrinol Metab; 2020 Oct; 105(10):3285-94. PubMed ID: 32706863
[TBL] [Abstract][Full Text] [Related]
12. Germline mutation profile of MEN1 in multiple endocrine neoplasia type 1: search for correlation between phenotype and the functional domains of the MEN1 protein.
Wautot V; Vercherat C; Lespinasse J; Chambe B; Lenoir GM; Zhang CX; Porchet N; Cordier M; Béroud C; Calender A
Hum Mutat; 2002 Jul; 20(1):35-47. PubMed ID: 12112656
[TBL] [Abstract][Full Text] [Related]
13. Higher risk of aggressive pancreatic neuroendocrine tumors in MEN1 patients with MEN1 mutations affecting the CHES1 interacting MENIN domain.
Bartsch DK; Slater EP; Albers M; Knoop R; Chaloupka B; Lopez CL; Fendrich V; Kann PH; Waldmann J
J Clin Endocrinol Metab; 2014 Nov; 99(11):E2387-91. PubMed ID: 25210877
[TBL] [Abstract][Full Text] [Related]
14. Multiple endocrine neoplasia type 1: clinical and genetic features of the hereditary endocrine neoplasias.
Marx SJ; Agarwal SK; Kester MB; Heppner C; Kim YS; Skarulis MC; James LA; Goldsmith PK; Saggar SK; Park SY; Spiegel AM; Burns AL; Debelenko LV; Zhuang Z; Lubensky IA; Liotta LA; Emmert-Buck MR; Guru SC; Manickam P; Crabtree J; Erdos MR; Collins FS; Chandrasekharappa SC
Recent Prog Horm Res; 1999; 54():397-438; discussion 438-9. PubMed ID: 10548885
[TBL] [Abstract][Full Text] [Related]
15. [Genetics of multiple endocrine neoplasies: clinical implications].
Igaz P; Gaillard RC
Rev Med Suisse; 2005 Feb; 1(6):408-13. PubMed ID: 15786644
[TBL] [Abstract][Full Text] [Related]
16. [Clinicogenetic study of MEN1: recent physiopathological data and clinical applications. Study Group of Multiple Endocrine Neoplasia (GENEM)].
Calender A; Giraud S; Porchet N; Gaudray P; Cadiot G; Mignon M
Ann Endocrinol (Paris); 1998; 59(6):444-51. PubMed ID: 10189986
[TBL] [Abstract][Full Text] [Related]
17. Deregulation of genetic pathways in neuroendocrine tumors.
Calender A; Vercherat C; Gaudray P; Chayvialle JA;
Ann Oncol; 2001; 12 Suppl 2():S3-11. PubMed ID: 11762348
[TBL] [Abstract][Full Text] [Related]
18. [Recent data on molecular genetics of neuroendocrine tumors].
Calender A
Ann Endocrinol (Paris); 1997; 58(2):113-23. PubMed ID: 9239229
[TBL] [Abstract][Full Text] [Related]
19. Coincidence of multiple endocrine neoplasia types 1 and 2: mutations in the RET protooncogene and MEN1 tumor suppressor gene in a family presenting with recurrent primary hyperparathyroidism.
Frank-Raue K; Rondot S; Hoeppner W; Goretzki P; Raue F; Meng W
J Clin Endocrinol Metab; 2005 Jul; 90(7):4063-7. PubMed ID: 15870131
[TBL] [Abstract][Full Text] [Related]
20. Molecular genetics of gastroenteropancreatic neuroendocrine tumors.
Starker LF; Carling T
Curr Opin Oncol; 2009 Jan; 21(1):29-33. PubMed ID: 19125015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
